News
October 15, 2025: A JAMA study promotes med spa regulation; a new documentary explores fake GLP-1s
A study says IV hydration spas need more oversight. Louisiana residents were hospitalized after receiving black market botulinum toxin injections. Hulu delved into the counterfeit GLP-1 market and Fierce Healthcare covered AFPs.
[...]Prescription Drug Freight Fraud Report, October 2025
What large-scale commercial imports made it into the country between March and August of 2025?
[...]Oregon State Pharmacy Association makes the case for PBM reform, not payment limits
This summer, Brian Mayo, Executive Director of the Oregon State Pharmacy Association (OSPA), made the case for pharmacy benefit manager (PBM) reform as a better way to rein in drug prices.
[...]October 7, 2025: PSM shares prescription drug freight fraud findings with Democratic governors
PSM Executive Director Shabbir Safdar is speaking at the Democratic Governors Association about the threat of unregulated prescription drugs smuggled into the U.S.
[...]Why are price cap proposals on medicines dangerous to pharmacies and patients?
Supply chain complexity means that upper payment limits and Medicare maximum fair prices will fall disproportionately on pharmacies, leading to closures that threaten patient access to care.
[...]September 30, 2025: Florida agency requests $4 million more for $132 million empty warehouse
Although the state won FDA approval for its importation program in January 2024, it has yet to implement the program.
[...]Med spas need stronger regulation
Medical spas and wellness clinics are operating on the edge of existing regulatory frameworks and it’s a risk to American patients.
[...]September 22, 2025: Chinese executives sentenced for shipping 200 kilos of fentanyl precursors into the U.S.
Between November 2022 and June 2023, Amarvel Biotech sold over 200 kilograms of precursor chemicals to U.S. buyers with full knowledge that they would be used to make fentanyl.
[...]Prescription Drug Freight Fraud Report, September 2025
Our analysis of data from June and July revealed hundreds of pharmaceutical shipments that entered the U.S. from facilities no one would expect, including unregistered Chinese exporters and alternative medicine clinics abroad.
[...]September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns FDA
The warning letter was one of about 100 is a new focus on deceptive direct-to-consumer drug advertisements.
[...]